Assessing Synopsys (SNPS) Valuation After NVIDIA GTC 2026 AI And GPU Design Announcements

NVIDIA’s GTC 2026 announcements put Synopsys (SNPS) at the center of a push to apply agentic AI and GPU acceleration across electronic design, simulation, and verification, highlighting new frameworks, customer workloads, and cross-industry engineering use cases.

See our latest analysis for Synopsys.

Despite the flurry of GTC 2026 announcements and new product launches, Synopsys shares have eased back. The 90 day share price return shows a decline of 6.43% and the year to date share price return shows a decline of 10.77%. However, the 5 year total shareholder return of 83.94% points to longer term momentum that has cooled recently.

If you like the AI angle in Synopsys but want a wider view of the space, it could be worth scanning 34 AI infrastructure stocks

With Synopsys trading around US$428.67 after recent share price declines, yet showing multi year shareholder gains and fresh AI partnerships with NVIDIA, is this a chance to gain exposure to physical AI tooling, or is the market already pricing in future growth?

Most Popular Narrative: 20.3% Undervalued

With Synopsys last closing at US$428.67 versus a narrative fair value of US$537.75, the current price sits well below what this widely followed model estimates. This sets up a detailed story built around growth, margins, and the Ansys combination.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Want to see what sits behind that confidence in future earnings, revenue, and margins? The narrative leans on ambitious growth, a richer IP mix, and a punchy future earnings multiple. Curious which specific forecasts justify that US$537.75 fair value and a double digit discount rate?

Result: Fair Value of $537.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this depends on EDA growth not slowing further, and on China and Intel related uncertainties easing instead of putting more pressure on Synopsys’ revenue mix.

Find out about the key risks to this Synopsys narrative.

Another View: Rich Multiples Versus Narrative Upside

The narrative model suggests Synopsys is 20.3% undervalued, yet the current P/E of 74.3x is far above both the US Software industry at 29.4x and peers at 40.3x, and above a fair ratio of 43.5x. This points to valuation risk if sentiment or growth assumptions soften. Which story do you trust more right now?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

The mixed signals on valuation and growth expectations make this a good moment to check the numbers yourself and decide where you stand. To weigh the balance between potential upside and the issues investors are watching, take a closer look at the 2 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Synopsys has your attention, do not stop here. The next step is lining up a few more high conviction ideas so you are not relying on a single stock.

• Target value opportunities by scanning 49 high quality undervalued stocks that combine quality fundamentals with potentially attractive entry points.
• Strengthen your income focus by reviewing 15 dividend fortresses built around higher yielding companies that still aim to keep payouts supported.
• Lean toward resilience by checking 73 resilient stocks with low risk scores where lower risk scores help you focus on steadier candidates for your watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com